Investment Management of Virginia’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-19,300
Closed -$888K 184
2022
Q4
$888K Sell
19,300
-120
-0.6% -$5.62K 0.17% 124
2022
Q3
$984K Sell
19,420
-55
-0.3% -$2.75K 0.21% 115
2022
Q2
$887K Hold
19,475
0.18% 119
2022
Q1
$905K Buy
19,475
+50
+0.3% +$2.24K 0.16% 132
2021
Q4
$976K Sell
19,425
-30
-0.2% -$1.55K 0.16% 131
2021
Q3
$1.03M Sell
19,455
-25
-0.1% -$1.41K 0.2% 115
2021
Q2
$1.19M Hold
19,480
0.23% 112
2021
Q1
$950K Sell
19,480
-200
-1% -$9.37K 0.19% 115
2020
Q4
$797K Hold
19,680
0.17% 113
2020
Q3
$640K Buy
+19,680
New +$591K 0.16% 112

Other funds holding LMAT

Investment Management of Virginia's LMAT Position: Q1 2023 in Review

Investment Management of Virginia sold out of LeMaitre Vascular (LMAT) in Q1 2023, closing a stake of 19,300 shares — an estimated $888K sold.

Investment Management of Virginia first reported a position in LMAT in Q3 2020 and held it in 10 quarters. The position peaked at $1.19M in Q2 2021. 184 funds tracked by Wall St. Rank hold LMAT as of Q1 2023.

  • Investment Management of Virginia reported no remaining LeMaitre Vascular position as of Q1 2023 after selling out during the quarter.
  • Investment Management of Virginia sold 19,300 LeMaitre Vascular shares in Q1 2023, an estimated $888K.
  • Investment Management of Virginia first reported a position in LeMaitre Vascular in Q3 2020 and held it in 10 quarters.
  • Investment Management of Virginia's LeMaitre Vascular position peaked at $1.19M in Q2 2021.
  • 184 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2023.

Based on Investment Management of Virginia's 13F filing for Q1 2023, filed 26 Apr 2023.